Back to search

Article

Lipopolymer Mediated siRNA Delivery Targeting Aberrant Oncogenes for Effective Therapy of Myeloid Leukemia

2023-07-31

Abstract excerpt

<title>Abstract</title> <p>In contrast to exploiting proteins as targets like most conventional drugs and tyrosine kinase inhibitors (TKI), that are rendered futile in the face of emerging drug resistance, RNA Interference (RNAi) exerts its therapeutic action towards disease-driving aberrant genes. To realize the potential of RNAi, the major challenge is to efficiently deliver the therapeutic mediator of RNAi, sm...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
eccc6ddb-8952-5a94-85e8-57b15a348131
DOI
10.21203/rs.3.rs-3201595/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Lipopolymer Mediated siRNA Delivery Targeting Aberrant Oncogenes for Effective Therapy of Myeloid LeukemiaDOI 10.21203/rs.3.rs-3201595/v1
Select a neighboring publication to make it the new centre.